CytomX Therapeutics, Inc. (CTMX): Price and Financial Metrics

CytomX Therapeutics, Inc. (CTMX)

Today's Latest Price: $5.30 USD

0.20 (-3.64%)

Updated Nov 13 12:00am

Add CTMX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

CTMX Stock Summary

  • Over the past twelve months, CTMX has reported earnings growth of 141.16%, putting it ahead of 91.55% of US stocks in our set.
  • As for revenue growth, note that CTMX's revenue has grown -27.97% over the past 12 months; that beats the revenue growth of merely 6.8% of US companies in our set.
  • CytomX Therapeutics Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -48.05%, greater than the shareholder yield of just 7.73% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to CytomX Therapeutics Inc are FPRX, CNAT, ATHX, BCRX, and ORMP.
  • Visit CTMX's SEC page to see the company's official filings. To visit the company's web site, go to
CTMX Daily Price Range
CTMX 52-Week Price Range

CTMX Stock Price Chart More Charts

CTMX Price/Volume Stats

Current price $5.30
Prev. close $5.50
Day low $5.30
Day high $5.58
50-day MA $7.40
200-day MA $10.38
52-week high $19.75
52-week low $5.28
Volume 459,500
Avg. volume 438,042
Dividend yield N/A
Market Cap 240.80M

CytomX Therapeutics, Inc. (CTMX) Company Bio

CytomX Therapeutics develops a novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology. The company was founded in 2008 and is based in San Francisco, California.

CTMX Latest News Stream

Event/Time News Detail
Loading, please wait...

CTMX Latest Social Stream

Loading social stream, please wait...

View Full CTMX Social Stream

CTMX Price Returns

1-mo -25.98%
3-mo -43.25%
6-mo -50.51%
1-year -61.51%
3-year -53.14%
5-year N/A
YTD -64.90%
2018 -28.47%
2017 92.08%
2016 -47.34%
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8118 seconds.